Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mansour Pharmaceutical Industries (MPI) is a prominent Egyptian pharmaceutical company and a key subsidiary of the Mansour Group, one of the largest conglomerates in the Middle East and North Africa. The company focuses on the development, manufacturing, and marketing of a wide range of high-quality generic pharmaceutical products across various therapeutic areas, including cardiology, gastroenterology, and infectious diseases. MPI operates state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards, enabling it to serve both the domestic Egyptian market and export markets. In addition to its own manufacturing, the company maintains strategic partnerships for the distribution of global pharmaceutical brands, leveraging the Mansour Group's extensive logistics network. MPI is dedicated to improving healthcare accessibility by providing affordable and effective therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mansour.